Table 5.
Total, n | Infection, n(%) | No infection n (%) | Corelation coefficient | Sig | χ2 | P-value | |
ACLF grade | 174 | 114 | 60 | 0.365 | 0.000 | 26.697 | 0.000 |
ACLF-1 | 41 | 15 (36.59) | 26 (63.41) | ||||
ACLF-2 | 51 | 31 (60.78) | 20 (39.22) | ||||
ACLF-3 | 82 | 68 (82.93) | 14 (17.07) | ||||
MELD | 174 | 114 | 60 | 0.285 | 0.001 | 15.421 | 0.001 |
< 20 | 87 | 46 (52.87) | 41 (47.13) | ||||
20-29 | 62 | 45 (72.58) | 17 (27.42) | ||||
30-39 | 21 | 19 (90.48) | 2 (9.52) | ||||
≥ 40 | 4 | 4 (100) | 0 | ||||
MELD-Na | 174 | 114 | 60 | 0.294 | 0.001 | 16.475 | 0.001 |
< 25 | 121 | 69 (57.02) | 52 (42.98) | ||||
25-34 | 31 | 23 (74.19) | 8 (25.81) | ||||
35-44 | 17 | 17 (100) | 0 | ||||
≥ 45 | 5 | 5 (100) | 0 | ||||
iMELD | 174 | 114 | 60 | 0.368 | 0.000 | 27.181 | 0.000 |
< 30 | 32 | 15 (46.88) | 17 (53.12) | ||||
30-39 | 74 | 39 (52.7) | 35 (47.3) | ||||
40-49 | 41 | 34 (82.93) | 7 (17.07) | ||||
50-59 | 20 | 19 (95) | 1 (5) | ||||
≥ 60 | 7 | 7 (100) | 0 | ||||
ALBI | 174 | 114 | 60 | 0.215 | 0.015 | 8.454 | 0.015 |
≤ -2.60 | 4 | 1 (25) | 3 (75) | ||||
-2.60~-1.39 | 49 | 26 (53.06) | 23 (46.94) | ||||
> -1.39 | 121 | 87 (71.9) | 34 (28.1) | ||||
CTP | 174 | 114 | 60 | 0.257 | 0.000 | 12.301 | 0.000 |
5-9 | 33 | 13 (39.4) | 20 (60.6) | ||||
≥ 10 | 141 | 101 (71.63) | 40 (28.37) |
CTP: Child-Turcotte-Pugh; MELD: Model for End-Stage Liver Disease; MELD-Na: MELD-sodium; iMELD: Integrated MELD; ALBI: Albumin-bilirubin; ACLF grade: Acute-on-chronic liver failure grade; ACLF-1: Acute-on-chronic liver failure grade 1; ACLF-2: Acute-on-chronic liver failure grade 2; ACLF-3: Acute-on-chronic liver failure grade 3.